Internal Medicine, Rheumatology · Jonesboro, AR
NPI
1003873019
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
2231 Hill Park Cove
Jonesboro, AR, 72401
Phone (870) 333-2721
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.8M
175,754 services
Medicare patients, 2024
632
Average age 72
Drug cost, 2024
$3.4M
8,969 prescriptions
Company payments, 2025
$1,024
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Leslie McCasland was code J0717 (injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)), 72,800 times for 28 patients. In total Leslie McCasland billed 175,754 services in 69 codes, and Medicare paid $1.8M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-01-18.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 72,800 | 28 | $3.60 | $262K |
| J1602 Injection, golimumab, 1 mg, for intravenous use | Office | 30,750 | 34 | $9.01 | $277K |
| J0897 Injection, denosumab, 1 mg | Office | 10,680 | 101 | $20.37 | $218K |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 10,141 | 104 | $0.10 | $1,021 |
| J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 7,400 | 18 | $33.76 | $250K |
| J9312 Injection, rituximab, 10 mg | Office | 7,150 | 25 | $61.21 | $438K |
| J2919 Injection, methylprednisolone sodium succinate, 5 mg | Office | 1,883 | 29 | $0.22 | $421 |
| 85025 Blood Count | Office | 1,122 | 355 | $7.48 | $8,390 |
| 80053 Clinical Chemistry | Office | 958 | 381 | $10.14 | $9,713 |
| 36415 Venipuncture Blood Collection | Office | 956 | 380 | $8.62 | $8,243 |
| 99213 Office E&M - Established | Office | 946 | 499 | $52.08 | $49K |
| 96401 Chemotherapy Administration | Office | 612 | 130 | $44.04 | $27K |
| 99214 Office E&M - Established | Office | 466 | 305 | $81.19 | $38K |
| 96413 Chemotherapy Administration | Office | 425 | 100 | $78.19 | $33K |
| 96415 Chemotherapy Administration | Office | 208 | 37 | $17.22 | $3,581 |
By year: 2022 $2.0M for 167,806 services; 2023 $2.2M for 169,712 services; 2024 $1.8M for 175,754 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 1,122 | 355 | $7.48 | $8,390 |
| 80053 Clinical Chemistry | 958 | 381 | $10.14 | $9,713 |
| 36415 Venipuncture Blood Collection | 956 | 380 | $8.62 | $8,243 |
| 82310 Clinical Chemistry | 102 | 66 | $5.03 | $513 |
| 81001 Clinical Chemistry | 39 | 32 | $3.06 | $119 |
Medicare prescription drug claims, 2024
In 2024, the drug Leslie McCasland prescribed most often to Medicare patients was Hydroxychloroquine Sulfate, with 763 prescriptions and refills. In total Leslie McCasland wrote 8,969 Medicare prescriptions that cost $3.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate Generic | 763 | 1,436 | 196 | $27K |
| Methotrexate Methotrexate Sodium | 689 | 1,102 | 151 | $12K |
| Tramadol Hcl Generic | 616 | 636 | 113 | $5,317 |
| Gabapentin Generic | 588 | 1,072 | 153 | $7,584 |
| Prednisone Generic | 510 | 789 | 142 | $3,323 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 385 | 385 | 63 | $8,223 |
| Duloxetine Hcl Generic | 360 | 650 | 94 | $5,654 |
| Meloxicam Generic | 328 | 614 | 83 | $1,614 |
| Alendronate Sodium Generic | 271 | 448 | 65 | $2,636 |
| Omeprazole Generic | 218 | 384 | 52 | $1,952 |
| Pregabalin Generic | 203 | 258 | 40 | $4,461 |
| Celecoxib Generic | 195 | 398 | 69 | $4,358 |
| Allopurinol Generic | 181 | 452 | 57 | $1,911 |
| Tizanidine Hcl Generic | 163 | 243 | 41 | $1,337 |
| Potassium Chloride Generic | 127 | 216 | 44 | $1,792 |
Brand drugs: - claims; generic drugs: 8,334 claims; opioid claims: 1,171.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Leslie McCasland $1,024 ($1,024 in general payments such as food, travel and fees) from 14 companies. The largest payer was Janssen Biotech, Inc. with $225.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 4 | $225 |
| Abbvie Inc. ABBV | 12 | $183 |
| Amgen Inc. AMGN | 17 | $169 |
| Novartis Pharmaceuticals Corporation NVS | 4 | $110 |
| UCB, Inc. UCB.BR | 4 | $93.75 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $45.5 |
| E.R. Squibb & Sons, L.L.C. BMY | 2 | $43.24 |
| Pfizer Inc. PFE | 2 | $41.55 |
| Lilly USA, LLC LLY | 1 | $24.86 |
| Mallinckrodt Hospital Products Inc. | 1 | $24.61 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.